IP Library › Granted Patent US 1,092,742
Granted Patent S1
US 1,092,742 · App. 29/884,634 · Granted Sep 9, 2025

Therapeutic gas cylinder bay

Inventors: Michael McAtamney (Navan, IE); Brian McCormack (Donabate, IE)
Assignee: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 1,092,742
App. No.
29/884,634
Granted
Sep 9, 2025
Kind
S1
Claims (1)

The ornamental design for a therapeutic gas cylinder bay as shown and described.

Assignments (8)
CORRECTIVE ASSIGNMENT TO CORRECT THE INCLUSION OF US PATENT 10828415 AND REMOVE IT FROM THE LISTING PREVIOUSLY RECORDED ON REEL 73375 FRAME 395. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Mar 6, 2026
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 075021/0263 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCLUSION OF US PATENT 10828415 AND REMOVE IT FROM THE LISTING PREVIOUSLY RECORDED ON REEL 72331 FRAME 1. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Mar 6, 2026
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 075021/0204 →
SECURITY INTEREST Recorded Oct 28, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 073375/0395 →
RELEASE OF SECURITY INTEREST Recorded Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
Reel/Frame 072324/0740 →
SECURITY INTEREST Recorded Aug 1, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 072331/0001 →
SECURITY INTEREST Recorded Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
CORRECTIVE ASSIGNMENT TO CORRECT THE THE ASSIGNOR: "MCATAMNY, MICH" SHOULD BE-- MCATAMNEY, MICHAEL-- PREVIOUSLY RECORDED AT REEL: 063007 FRAME: 0284. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Mar 21, 2023
From: MCATAMNEY, MICHAEL; MCCORMACK, BRIAN
To: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 063123/0017 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2023
From: MCATAMNEY, MICH; MCCORMACK, BRIAN
To: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 063007/0284 →
References Cited (104)
US 5558083A · Bathe et al. · 1996 [cited by applicant]
US 5732693A · Bathe et al. · 1998 [cited by applicant]
US 5752504A · Bathe · 1998 [cited by applicant]
US 5827950A · Woodbury et al. · 1998 [cited by applicant]
US 6089229A · Bathe et al. · 2000 [cited by applicant]
US 6125846A · Bathe et al. · 2000 [cited by applicant]
US 6164276A · Bathe et al. · 2000 [cited by applicant]
US 6543444B1 · Lewis · 2003 [cited by applicant]
US D530854S · Xu · 2006 [cited by examiner]
US 7159608B1 · Lucas, Jr. et al. · 2007 [cited by applicant]
US D549342S · Ross · 2007 [cited by examiner]
US D590505S · Mazoyer · 2009 [cited by examiner]
US 7523752B2 · Montgomery et al. · 2009 [cited by applicant]
US 7768409B2 · Parias · 2010 [cited by applicant]
US 8282966B2 · Baldassarre et al. · 2012 [cited by applicant]
US 8291904B2 · Bathe et al. · 2012 [cited by applicant]
US 8293284B2 · Baldassarre et al. · 2012 [cited by applicant]
US 8366815B2 · Taylor · 2013 [cited by examiner]
US 8431163B2 · Baldassarre et al. · 2013 [cited by applicant]
US 8573209B2 · Bathe et al. · 2013 [cited by applicant]
US 8573210B2 · Bathe et al. · 2013 [cited by applicant]
US D700701S · Taylor · 2014 [cited by examiner]
US D701963S · Abarbanel · 2014 [cited by examiner]
US 8757148B2 · Montgomery et al. · 2014 [cited by applicant]
US 8776794B2 · Bathe et al. · 2014 [cited by applicant]
US 8776795B2 · Bathe et al. · 2014 [cited by applicant]
US 8795741B2 · Baldassarre · 2014 [cited by applicant]
US 8846112B2 · Baldassarre · 2014 [cited by applicant]
US D729936S · Reback · 2015 [cited by examiner]
US D729937S · Acker · 2015 [cited by examiner]
US D730525S · Acker · 2015 [cited by examiner]
US 9816642B2 · Fowler et al. · 2017 [cited by applicant]
US D808017S · Ito · 2018 [cited by examiner]
US D861874S · Hirano · 2019 [cited by examiner]
US D884187S · Robert · 2020 [cited by examiner]
US 10953187B2 · Galbraith · 2021 [cited by examiner]
US D930835S · Taylor · 2021 [cited by examiner]
US D1069120S · Mao · 2025 [cited by examiner]
US 20030189492A1 · Harvie · 2003 [cited by applicant]
US 20050004511A1 · Figley et al. · 2005 [cited by applicant]
US 20060283517A1 · McCulloh et al. · 2006 [cited by applicant]
US 20080150739A1 · Gamard · 2008 [cited by applicant]
US 20100003349A1 · Miller · 2010 [cited by examiner]
US 20100030917A1 · Kaneko · 2010 [cited by applicant]
US 20110140850A1 · Wassel et al. · 2011 [cited by applicant]
US 20120080103A1 · Levine et al. · 2012 [cited by applicant]
US 20120116292A1 · Montgomery et al. · 2012 [cited by applicant]
US 20120226451A1 · Bacot et al. · 2012 [cited by applicant]
US 20140048063A1 · Bathe et al. · 2014 [cited by applicant]
US 20140127081A1 · Fine et al. · 2014 [cited by applicant]
CN 2024303015446 · 2024 [cited by examiner]
EP 0659445A1 · 1995 [cited by applicant]
EP 0960629A2 · 1999 [cited by applicant]
WO 9844976A1 · 1998 [cited by applicant]
WO 9922796A1 · 1999 [cited by applicant]
WO 9959662A1 · 1999 [cited by applicant]
WO 0195972A2 · 2001 [cited by applicant]
WO 2008112423A1 · 2008 [cited by applicant]
WO 2010044039A2 · 2010 [cited by applicant]
WO 2011084538A2 · 2011 [cited by applicant]
WO 2012094008A1 · 2012 [cited by applicant]
WO 2013054217A1 · 2013 [cited by applicant]
WO 2014144184A2 · 2014 [cited by applicant]
WO 2016096056A1 · 2016 [cited by applicant]
Z&HA Oxygen Concentrator, Online, Published date Sep. 1, 2021, Retrieved on May 14, 2024 from URL: https://www.amazon.de/-/en/Portable-Concentrator-Intelligent-Adjustable-Humidifier/dp/B09F62Y5PT (Year: 2021). [cited by examiner]
Annex to Form PCT/ISA/206 Communication Related to the Results of the Partial International Search in PCT/US2015/030217, dated Aug. 4, 2015, 7 pages. [cited by applicant]
English Translation of Abstract of Japanese Application H09299485,1 page. [cited by applicant]
English Translation of Abstract of Japanese Application No. 2010508877A, 1 page. [cited by applicant]
European Search Report in European Application No. 19168698.9 dated Oct. 22, 2019,16 pages. [cited by applicant]
Examination Report No. 1 for Australian Application No. 2022211800, mailed on Nov. 16, 2023, 4 pages. [cited by applicant]
Examination Report No. 1 for Australian Patent Application No. 2021204009 dated Mar. 16, 2022, 2 Pages. [cited by applicant]
Extended European Search Report for Application No. EP19168698.9, dated Jan. 24, 2020,14 Pages. [cited by applicant]
Extended European Search Report for European Application No. 23215086.2, mailed on Feb. 12, 2024, 10 pages. [cited by applicant]
Final Office Action in U.S. Appl. No. 14/709,316, dated Sep. 5, 2018,11 pages. [cited by applicant]
INOblender Operations Manual, Ikaria, Inc. 2010, 34 pages. [cited by applicant]
INOmax DS (Delivery System): Operation Manual (800 ppm INOmax (nitric oxide) for Inhalation), Ikaria, Inc. 2010, 112 pages. [cited by applicant]
INOmax DSIR (Delivery System): Operation Manual (800 ppm INOmax (nitric oxide) for Inhalation), Ikaria, Inc. 2012, 136 pages. [cited by applicant]
INOmax DS.sub.IR INOblender—Pre-Use Checkout, Ikaria, Inc. 2014, 2 pages. [cited by applicant]
INOmax Label, Nitric Oxide Gas, INO Therapeutics 2013, 2 pages. [cited by applicant]
INOvent Delivery System: Operation and Maintenance Manual (CGA Variant), Datex-Ohmeda, Inc. 2000, 180 pages. [cited by applicant]
International Preliminary Report on Patentability for International PCT Patent Application No. PCT/US2015/030217, mailed on Nov. 24, 2016, 17 pages. [cited by applicant]
International Search Report and Written Opinion in PCT/US2015/030217, dated Oct. 19, 2015, 23 pages. [cited by applicant]
Japanese Office Action in Japanese Application No. 2017-511572 dated Mar. 19, 2019, 8 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/748,319 dated May 24, 2022, 18 pages. [cited by applicant]
Non-Final Office Action in U.S. Appl. No. 16/825,840 dated May 7, 2020, 11 pages. [cited by applicant]
Non-Final Office Action in U.S. Appl. No. 16/825,848 dated May 7, 2020, 8 pages. [cited by applicant]
Non-Final Office Action in U.S. Appl. No. 16/217,969, issued May 7, 2020, 8 pages. [cited by applicant]
Office Action dated May 3, 2021 for Canadian Patent Application No. 2941761, 5 Pages. [cited by applicant]
Office Action for Australian Application No. 2015255688 dated Jun. 7, 2019 , 5 pages. [cited by applicant]
Office Action for Canadian Application No. 2,941,761 mailed on Jul. 28, 2023, 4 pages. [cited by applicant]
Office Action for Canadian Application No. 3,138,339, mailed on Jan. 17, 2023, 3 pages. [cited by applicant]
Office Action for Canadian Application No. 3,138,342 mailed on Nov. 7, 2023, 4 pages. [cited by applicant]
Office Action for Canadian Application No. 3,142,415, mailed on Jan. 18, 2023, 4 pages. [cited by applicant]
Office Action for Canadian Patent Application No. 2941761, mailed Feb. 11, 2022, 4 Pages. [cited by applicant]
Office Action for European Application No. 19168698.9, mailed on Oct. 14, 2022, 6 pages. [cited by applicant]
Office Action for Japanese Patent Application No. 2017511572, mailed Sep. 21, 2021, 6 Pages. [cited by applicant]
Office Action for Mexican Application No. MX/a/2021/007810 mailed on Jul. 15, 2022, 7 pages. [cited by applicant]
Office action for Mexican Application No. MX/a/2021/007814 dated Jun. 30, 2022, 9 pages. [cited by applicant]
Office Action for Mexican Application No. MX/a/2021/007816, mailed on Oct. 7, 2022, 6 pages. [cited by applicant]
Office action regarding U.S. Appl. No. 14/709,316 dated Feb. 1, 2018, 10 pages. [cited by applicant]
Office action regarding U.S. Appl. No. 14/709,316 dated Feb. 26, 2019, 11 pages. [cited by applicant]
Partial European Search Report for European Application No. 23215095.3, mailed on Feb. 12, 2024, 15 Pages. [cited by applicant]
Using the INOpulse DS Subject Guide, Ikaria, Inc. 2012, 50 pages. [cited by applicant]
Office Action dated Jul. 24, 2023 for New Zealand Patent Application No. 432323, 2 Pages. [cited by applicant]